Bilan hématologique en cas de fausses couches précoces à répétition : quelles évidences ? [Hematological workup in cases of recurrent early miscarriages: what evidences?]
Fiche du document
18 octobre 2023
- doi: 10.53738/REVMED.2023.19.846.1911
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.846.1911
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37850803
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3791172B44042
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2025-04-18 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Mechanical properties testingCiter ce document
D. Choffat et al., « Bilan hématologique en cas de fausses couches précoces à répétition : quelles évidences ? [Hematological workup in cases of recurrent early miscarriages: what evidences?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.846.1911
Métriques
Partage / Export
Résumé
Recurrent miscarriages have a major psychological and somatic impact, as well as a significant economic burden. An etiological work-up should be offered after two or three miscarriages, the threshold varying from one scientific society to another. However, the proposed biological work-up must be justified by scientific evidence. A simple blood count, basic coagulation tests including fibrinogen assay and anti-phospholipid antibodies testing should be performed initially. Hereditary thrombophilia testing should only be carried out if there is a history of maternal thrombosis. In the event of an abnormality, management should be multidisciplinary, and the prescription of medication should follow recommended guidelines. Prophylactic treatment is not justified in the absence of a known etiology.